Recent ZNTL News
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 09/17/2024 01:38:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:02:19 AM
- Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024 • GlobeNewswire Inc. • 09/09/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/03/2024 08:40:50 PM
- Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL • Business Wire • 08/19/2024 08:55:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 11:03:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 11:01:42 AM
- Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress • GlobeNewswire Inc. • 08/09/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/01/2024 10:00:00 PM
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 07/25/2024 06:49:00 PM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/01/2024 10:00:47 PM
- Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program • GlobeNewswire Inc. • 06/18/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/03/2024 10:00:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:00:53 AM
- Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2024 11:16:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 11:04:29 AM
- Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:01:39 PM
- Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:05:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:03:04 AM
- Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/01/2024 09:30:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM